Market Overview
The global Brain Neurointerventional Device market was valued at USD 12.17 billion in 2024 and is projected to reach USD 68.79 billion by 2031, exhibiting a CAGR of 28.8% during the forecast period.
Brain neurointerventional devices are specialized medical instruments designed for the diagnosis and treatment of cerebrovascular diseases, including ischemic and hemorrhagic strokes. These devices enable minimally invasive procedures such as thrombectomy, aneurysm coiling, and stent placement, significantly improving patient outcomes while reducing recovery times compared to traditional surgical methods.
68.79 billion by 2031 USD 12.17 billion in 2024
of 28.8%
Thrombectomy Devices
Intracranial Stents
Embolization Coils
Balloon Catheters
Thrombectomy Devices hold the largest market share due to increasing incidence of ischemic strokes and the critical need for rapid intervention. Technological advancements enabling precise clot removal drive adoption across neurological centers globally.
By Application
Ischemic Stroke Intervention
Cerebral Aneurysm Treatment
Arteriovenous Malformations
Other Neurovascular Conditions
Ischemic Stroke Intervention dominates segment share as neurointerventional devices become first-line treatment for acute ischemic stroke. Growing geriatric population with higher stroke risk fuels demand, while minimally invasive techniques reduce recovery time compared to traditional surgery.
Portable Neuromonitoring Device Market
https://www.24lifesciences.com
Our Key Players
Medtronic plc (Ireland)
Stryker Corporation (U.S.)
Johnson & Johnson (U.S.)
Terumo Corporation (Japan)
Medtronic plc (Ireland)
Penumbra, Inc. (U.S.)
https://www.24lifesciences.com
